Inhibition of SIRT6 potentiates the anti-tumor effect of doxorubicin through suppression of the DNA damage repair pathway in osteosarcoma

被引:0
作者
Zhongkai Zhang
Sang Hoon Ha
Young Jae Moon
Usama Khamis Hussein
Yiping Song
Kyoung Min Kim
See-Hyoung Park
Ho Sung Park
Byung-Hyun Park
Ae-Ri Ahn
Sang-A Lee
Su Jin Ahn
Jung Ryul Kim
Kyu Yun Jang
机构
[1] Jeonbuk National University Medical School,Department of Orthopedic Surgery
[2] Jeonbuk National University,Division of Biotechnology
[3] Jeonbuk National University Medical School,Department of Biochemistry and Molecular Biology
[4] Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital and Research Institute for Endocrine Sciences,Department of Pathology
[5] Jeonbuk National University Medical School,Faculty of Science
[6] Beni-Suef University,Department of Bio and Chemical Engineering
[7] Hongik University,undefined
来源
Journal of Experimental & Clinical Cancer Research | / 39卷
关键词
Osteosarcoma; SIRT6; doxorubicin; apoptosis; DNA damage;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 331 条
[1]  
Lombard DB(2008)SIRT6 in DNA repair, metabolism and ageing J Intern Med 263 128-41
[2]  
Schwer B(2011)SIRT6 promotes DNA repair under stress by activating PARP1 Science 332 1443-6
[3]  
Alt FW(2006)Genomic instability and aging-like phenotype in the absence of mammalian SIRT6 Cell 124 315-29
[4]  
Mostoslavsky R(2019)Sirtuins and SIRT6 in Carcinogenesis and in Diet Int J Mol Sci. 20 19-99
[5]  
Mao Z(2012)The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism Cell 151 1185-21
[6]  
Hine C(2012)The sirtuin SIRT6 regulates lifespan in male mice Nature 483 218-3000
[7]  
Tian X(2013)The histone deacetylase SIRT6: at the crossroads between epigenetics, metabolism and disease Curr Top Med Chem 13 2991-50
[8]  
Van Meter M(2016)Evidence for a role of the histone deacetylase SIRT6 in DNA damage response of multiple myeloma cells Blood 127 1138-68
[9]  
Au M(1998)Prognostic and predictive factors in breast cancer by immunohistochemical analysis Mod Pathol 11 155-12
[10]  
Vaidya A(2017)Sensitizing thermochemotherapy with a PARP1-inhibitor Oncotarget 8 16303-67